Unknown NA INTERVENTIONAL 2-arm NCT04392713

Efficacy of Ivermectin in COVID-19

Efficacy of Ivermectin in COVID-19 : A Randomized Controlled Trial

Sponsor: Combined Military Hospital, Pakistan

Conditions COVID

Interventions Ivermectin 6 MG Oral Tablet (2 tablets)

Updated 5 times since 2020 Last updated: May 17, 2020 Started: Apr 15, 2020 Primary completion: Jul 31, 2020 Completion: Jul 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04392713, this NA trial focuses on COVID and remains ongoing. Sponsored by Combined Military Hospital, Pakistan, it has been updated 5 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jun 2022 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Jun 2022 [monthly]

Recruiting NA
Jun 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Apr 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Combined Military Hospital, Pakistan

Data source: Combined Military Hospital, Pakistan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lahore, Pakistan